OMZELCY
LIVE

Serial Number

99659130

Owner

Zentalis Pharmaceuticals, Inc.

Attorney

Christopher K. Albert

Filing Date

Feb 18, 2026

Add to watchlist:

No watchlists yet
View on USPTO

OMZELCY Trademark

Serial Number: 99659130

OMZELCY is a trademark filed by Zentalis Pharmaceuticals, Inc. on February 18, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Zentalis Pharmaceuticals, Inc. (13 trademarks)

10835 Road to the Cure, Suite 205
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

February 18, 2026

Registration Date

Not Registered

Goods & Services

Providing medical information in the field of cancer, tumors, and the treatment of cancer and tumors; Providing a web site featuring medical information; Medical information services provided via the Internet; Providing a website featuring medical information in the field of cancer, tumors, and the treatment of cancer and tumors; Providing educational information relating to cancer, tumors, and treatment for cancer and tumors; Providing educational information via the internet relating to cancer, tumors, and treatment for cancer and tumors; Providing a website featuring medical information in the field of ovarian cancer and the treatment of ovarian cancer; Providing educational information relating to ovarian cancer and treatment for ovarian cancer; Providing educational information via the internet relating to ovarian cancer and treatment for ovarian cancer

Pharmaceutical products for the treatment of cancer; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations and substances; Pharmaceutical preparations and substances for the treatment of ovarian cancer

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 31, 2026 GNRN
NON-FINAL ACTION E-MAILED
Mar 31, 2026 GNRT
NON-FINAL ACTION WRITTEN
Mar 31, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 26, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 18, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 18, 2026 NWOS
NEW APPLICATION ENTERED
Feb 18, 2026 NWAP